49750-74-5 Usage
Derivative of phenylamine
Phenylamine is the base structure from which 2-(2-METHOXY-ETHOXY)-5-TRIFLUOROMETHYL-PHENYLAMINE is derived. It is an aromatic compound with an amine group (-NH2) attached to a benzene ring.
Trifluoromethyl group
A trifluoromethyl group (-CF3) is also attached to the phenyl ring in 2-(2-METHOXY-ETHOXY)-5-TRIFLUOROMETHYL-PHENYLAMINE. This functional group consists of a carbon atom bonded to three fluorine atoms and can influence the compound's reactivity, stability, and solubility.
Potential applications in pharmaceuticals and agrochemicals
Due to its unique structural features and functional groups, 2-(2-METHOXY-ETHOXY)-5-TRIFLUOROMETHYL-PHENYLAMINE may have potential uses in the development of pharmaceuticals and agrochemicals.
Synthesis of various organic compounds
The compound may be used as a building block or intermediate in the synthesis of other organic compounds, contributing to the formation of more complex molecules.
Biological activities of interest
2-(2-METHOXY-ETHOXY)-5-TRIFLUOROMETHYL-PHENYLAMINE may exhibit biological activities that are relevant for medicinal and agricultural purposes, such as acting as a pesticide, herbicide, or pharmaceutical drug.
Need for further research
To fully understand the properties and potential uses of 2-(2-METHOXY-ETHOXY)-5-TRIFLUOROMETHYL-PHENYLAMINE, additional research is required. This includes studying its chemical reactivity, stability, solubility, and potential biological activities.
Check Digit Verification of cas no
The CAS Registry Mumber 49750-74-5 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 4,9,7,5 and 0 respectively; the second part has 2 digits, 7 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 49750-74:
(7*4)+(6*9)+(5*7)+(4*5)+(3*0)+(2*7)+(1*4)=155
155 % 10 = 5
So 49750-74-5 is a valid CAS Registry Number.
49750-74-5Relevant academic research and scientific papers
N-(MONOCYCLIC ARYL),N'-PYRAZOLYL-UREA, THIOUREA, GUANIDINE AND CYANOGUANIDINE COMPOUNDS AS TRKA KINASE INHIBITORS
-
Paragraph 00505; 00506, (2014/06/11)
Compounds of Formula (I) or stereoisomers, tautomers, or pharmaceutically acceptable salts, solvates or prodrugs thereof, wherein Ring A, Ring C and X are as defined herein, are inhibitors of TrkA kinase and are useful in the treatment of diseases which can be treated with a TrkA kinase inhibitor such as pain, cancer, inflammation/inflammatory diseases, neurodegenerative diseases, certain infectious diseases, Sjogren's syndrome, endometriosis, diabetic peripheral neuropathy, prostatitis or pelvic pain syndrome.
SEMICARBAZIDE DERIVATIVES AS KINASE INHIBITORS
-
Page/Page column 220, (2008/06/13)
The present invention relates to semicarbazide derivatives of formula I, the use of the compounds of formula I as inhibitors of one or more kinases, the use of the compounds of formula I for the manufacture of a pharmaceutical composition and a method of treatment, comprising administering said pharmaceutical composition to a patient.
BISARYLUREA DERIVATIVES
-
Page/Page column 224, (2010/02/13)
The present invention relates to bisarylurea derivatives of formula (I), the use of the compounds of formula (I) as inhibitors of raf-kinase, the use of the compounds of formula (I) for the manufacture of a pharmaceutical composition and a method of treatment, comprising administering said pharmaceutical composition to a patient.
